Ceftriaxone (marketed as Rocephin and generics)
MedSun: Newsletter #36, May 2009
FDA notified healthcare professionals of an update to a previous alert on the interaction of ceftriaxone with calcium-containing products, based on previously reported fatal cases in neonates. Based on the results of new studies FDA now recommends that ceftriaxone and calcium-containing products may be used concomitantly in patients over 28 days of age, using the precautionary recommendations noted because the risk of precipitation is low in this population.
Ceftriaxone (marketed as Rocephin and generics). FDA MedWatch Alert. April 14, 2009.
Information for Healthcare Professionals: Ceftriaxone (marketed as Rocephin and generics). April 21, 2009.